市場調査レポート
商品コード
1626128

ウィメンズヘルス向け治療薬の世界市場 (2024~2028年)

Global Women Health Therapeutics Market 2024-2028


出版日
発行
TechNavio
ページ情報
英文 180 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.26円
ウィメンズヘルス向け治療薬の世界市場 (2024~2028年)
出版日: 2024年11月28日
発行: TechNavio
ページ情報: 英文 180 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ウィメンズヘルス向け治療薬市場 (2024~2028年)

ウィメンズヘルス (女性の健康) 向け治療薬市場は2023年から2028年に372億米ドル分拡大し、予測期間中に6%のCAGRで成長すると予測されます。当レポートでは、ウィメンズヘルス向け治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。この市場は、ウィメンズヘルス (女性の健康) に対する関心増大や、強力な医薬品承認の数々、戦略的提携によって牽引されています。

市場範囲
基準年 2024年
終了年 2028年
予測期間 2024~2028年
成長モメンタム 加速
前年比 (2024年) 5.6%
CAGR 6%
増分額 372億米ドル

当レポートでは、今後数年間のウィメンズヘルス向け治療薬市場の成長を牽引する主な要因の1つとして、婦人科疾患に対する意識の高まりを挙げています。また、新しい治療法の出現や抗生物質耐性に対する政府の取り組みの高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavioによる分析

  • 価格感応度・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 (2023年)
  • 市場の見通し (2023~2028年)

第5章 市場規模実績

  • 世界のウィメンズヘルス向け治療薬市場 (2018~2022年)
  • 種類別分析 (2018~2022年)
  • 地域別分析 (2018~2022年)
  • 国別分析 (2018~2022年)

第6章 定性分析

  • AIの影響:世界のウィメンズヘルス向け治療薬市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場区分:種類別

  • 市場区分
  • 比較:種類別
  • 生殖能力:市場規模と予測 (2023~2028年)
  • 腫瘍学:市場規模と予測 (2023~2028年)
  • 閉経:市場規模と予測 (2023~2028年)
  • 感染:市場規模と予測 (2023~2028年)
  • その他:市場規模と予測 (2023~2028年)
  • 市場機会:種類別

第9章 顧客情勢

  • 顧客情勢の概要

第10章 地域別情勢

  • 地域別区分
  • 地域別比較
  • 北米:市場規模と予測 (2023~2028年)
  • 欧州:市場規模と予測 (2023~2028年)
  • アジア:市場規模と予測 (2023~2028年)
  • 世界のその他の地域:市場規模と予測 (2023~2028年)
  • 米国:市場規模と予測 (2023~2028年)
  • ドイツ:市場規模と予測 (2023~2028年)
  • 英国:市場規模と予測 (2023~2028年)
  • 中国:市場規模と予測 (2023~2028年)
  • カナダ:市場規模と予測 (2023~2028年)
  • フランス:市場規模と予測 (2023~2028年)
  • 日本:市場規模と予測 (2023~2028年)
  • メキシコ:市場規模と予測 (2023~2028年)
  • 韓国:市場規模と予測 (2023~2028年)
  • ブラジル:市場規模と予測 (2023~2028年)
  • 市場機会:地域情勢別

第11章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第12章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第13章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • ICON plc
  • Merck KGaA
  • Mithra Pharmaceuticals SA
  • Novartis AG

第14章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Company Market Positioning
  • Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits10: Overview on criticality of inputs and factors of differentiation
  • Exhibits11: Overview on factors of disruption
  • Exhibits12: Impact of drivers and challenges in 2023 and 2028
  • Exhibits13: Parent Market
  • Exhibits14: Data Table on - Parent Market
  • Exhibits15: Market characteristics analysis
  • Exhibits16: Value Chain Analysis
  • Exhibits17: Offerings of companies included in the market definition
  • Exhibits18: Market segments
  • Exhibits19: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits20: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits21: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits22: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits23: Historic Market Size - Data Table on Global Women Health Therapeutics Market 2018 - 2022 ($ billion)
  • Exhibits24: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • Exhibits25: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits26: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits27: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits28: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits29: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits31: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits32: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits33: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits34: Chart on Type - Market share 2023-2028 (%)
  • Exhibits35: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits36: Chart on Comparison by Type
  • Exhibits37: Data Table on Comparison by Type
  • Exhibits38: Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Fertility - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Fertility - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on Oncology - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Chart on Menopause - Market size and forecast 2023-2028 ($ billion)
  • Exhibits47: Data Table on Menopause - Market size and forecast 2023-2028 ($ billion)
  • Exhibits48: Chart on Menopause - Year-over-year growth 2023-2028 (%)
  • Exhibits49: Data Table on Menopause - Year-over-year growth 2023-2028 (%)
  • Exhibits50: Chart on Infection - Market size and forecast 2023-2028 ($ billion)
  • Exhibits51: Data Table on Infection - Market size and forecast 2023-2028 ($ billion)
  • Exhibits52: Chart on Infection - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on Infection - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits55: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits56: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits57: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits58: Market opportunity by Type ($ billion)
  • Exhibits59: Data Table on Market opportunity by Type ($ billion)
  • Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits63: Chart on Geographic comparison
  • Exhibits64: Data Table on Geographic comparison
  • Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits102: Data Table on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits103: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Mexico - Market size and forecast 2023-2028 ($ billion)
  • Exhibits110: Data Table on Mexico - Market size and forecast 2023-2028 ($ billion)
  • Exhibits111: Chart on Mexico - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on South Korea - Market size and forecast 2023-2028 ($ billion)
  • Exhibits114: Data Table on South Korea - Market size and forecast 2023-2028 ($ billion)
  • Exhibits115: Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Exhibits118: Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Exhibits119: Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits120: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits121: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits122: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits123: Impact of drivers and challenges in 2023 and 2028
  • Exhibits124: Overview on criticality of inputs and factors of differentiation
  • Exhibits125: Overview on factors of disruption
  • Exhibits126: Impact of key risks on business
  • Exhibits127: Companies covered
  • Exhibits128: Company ranking index
  • Exhibits129: Matrix on companies position and classification
  • Exhibits130: Abbott Laboratories - Overview
  • Exhibits131: Abbott Laboratories - Business segments
  • Exhibits132: Abbott Laboratories - Key news
  • Exhibits133: Abbott Laboratories - Key offerings
  • Exhibits134: Abbott Laboratories - Segment focus
  • Exhibits135: SWOT
  • Exhibits136: AbbVie Inc. - Overview
  • Exhibits137: AbbVie Inc. - Product / Service
  • Exhibits138: AbbVie Inc. - Key news
  • Exhibits139: AbbVie Inc. - Key offerings
  • Exhibits140: SWOT
  • Exhibits141: Amgen Inc. - Overview
  • Exhibits142: Amgen Inc. - Product / Service
  • Exhibits143: Amgen Inc. - Key news
  • Exhibits144: Amgen Inc. - Key offerings
  • Exhibits145: SWOT
  • Exhibits146: Bayer AG - Overview
  • Exhibits147: Bayer AG - Business segments
  • Exhibits148: Bayer AG - Key news
  • Exhibits149: Bayer AG - Key offerings
  • Exhibits150: Bayer AG - Segment focus
  • Exhibits151: SWOT
  • Exhibits152: Eli Lilly and Co. - Overview
  • Exhibits153: Eli Lilly and Co. - Product / Service
  • Exhibits154: Eli Lilly and Co. - Key offerings
  • Exhibits155: SWOT
  • Exhibits156: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits157: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits158: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits159: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits160: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits161: SWOT
  • Exhibits162: ICON plc - Overview
  • Exhibits163: ICON plc - Product / Service
  • Exhibits164: ICON plc - Key offerings
  • Exhibits165: SWOT
  • Exhibits166: Merck KGaA - Overview
  • Exhibits167: Merck KGaA - Business segments
  • Exhibits168: Merck KGaA - Key news
  • Exhibits169: Merck KGaA - Key offerings
  • Exhibits170: Merck KGaA - Segment focus
  • Exhibits171: SWOT
  • Exhibits172: Mithra Pharmaceuticals SA - Overview
  • Exhibits173: Mithra Pharmaceuticals SA - Product / Service
  • Exhibits174: Mithra Pharmaceuticals SA - Key offerings
  • Exhibits175: SWOT
  • Exhibits176: Novartis AG - Overview
  • Exhibits177: Novartis AG - Business segments
  • Exhibits178: Novartis AG - Key news
  • Exhibits179: Novartis AG - Key offerings
  • Exhibits180: Novartis AG - Segment focus
  • Exhibits181: SWOT
  • Exhibits182: Inclusions checklist
  • Exhibits183: Exclusions checklist
  • Exhibits184: Currency conversion rates for US$
  • Exhibits185: Research methodology
  • Exhibits186: Information sources
  • Exhibits187: Data validation
  • Exhibits188: Validation techniques employed for market sizing
  • Exhibits189: Data synthesis
  • Exhibits190: 360 degree market analysis
  • Exhibits191: List of abbreviations
目次
Product Code: IRTNTR74260

Women Health Therapeutics Market 2024-2028

The women health therapeutics market is forecasted to grow by USD 37.2 bn during 2023-2028, accelerating at a CAGR of 6% during the forecast period. The report on the women health therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing attention toward women health, array of strong drug approvals, and strategic alliances.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.6%
CAGR6%
Incremental Value$37.2 bn

Technavio's women health therapeutics market is segmented as below:

By Type

    • Fertility
    • Oncology
    • Menopause
    • Infection
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the rising awareness of gynecological diseases as one of the prime reasons driving the women health therapeutics market growth during the next few years. Also, emergence of novel therapies and rising government initiatives to antibiotic resistance will lead to sizable demand in the market.

The report on the women health therapeutics market covers the following areas:

    • Women Health Therapeutics Market sizing
    • Women Health Therapeutics Market forecast
    • Women Health Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading women health therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Mithra Pharmaceuticals SA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Tsumura and Co., and Vivesto AB. Also, the women health therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Women Health Therapeutics Market 2018 - 2022
    • Historic Market Size - Data Table on Global Women Health Therapeutics Market 2018 - 2022 ($ billion)
  • 5.2 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • 5.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 5.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Women Health Therapeutics Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

  • 8.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 8.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 8.3 Fertility - Market size and forecast 2023-2028
    • Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
    • Chart on Fertility - Year-over-year growth 2023-2028 (%)
    • Data Table on Fertility - Year-over-year growth 2023-2028 (%)
  • 8.4 Oncology - Market size and forecast 2023-2028
    • Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
    • Chart on Oncology - Year-over-year growth 2023-2028 (%)
    • Data Table on Oncology - Year-over-year growth 2023-2028 (%)
  • 8.5 Menopause - Market size and forecast 2023-2028
    • Chart on Menopause - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Menopause - Market size and forecast 2023-2028 ($ billion)
    • Chart on Menopause - Year-over-year growth 2023-2028 (%)
    • Data Table on Menopause - Year-over-year growth 2023-2028 (%)
  • 8.6 Infection - Market size and forecast 2023-2028
    • Chart on Infection - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Infection - Market size and forecast 2023-2028 ($ billion)
    • Chart on Infection - Year-over-year growth 2023-2028 (%)
    • Data Table on Infection - Year-over-year growth 2023-2028 (%)
  • 8.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 8.8 Market opportunity by Type
    • Market opportunity by Type ($ billion)
    • Data Table on Market opportunity by Type ($ billion)

9 Customer Landscape

  • 9.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

  • 10.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 10.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 10.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 10.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 10.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 10.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 10.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 10.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 10.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 10.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 10.11 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 10.12 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ billion)
    • Data Table on France - Market size and forecast 2023-2028 ($ billion)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 10.13 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 10.14 Mexico - Market size and forecast 2023-2028
    • Chart on Mexico - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Mexico - Market size and forecast 2023-2028 ($ billion)
    • Chart on Mexico - Year-over-year growth 2023-2028 (%)
    • Data Table on Mexico - Year-over-year growth 2023-2028 (%)
  • 10.15 South Korea - Market size and forecast 2023-2028
    • Chart on South Korea - Market size and forecast 2023-2028 ($ billion)
    • Data Table on South Korea - Market size and forecast 2023-2028 ($ billion)
    • Chart on South Korea - Year-over-year growth 2023-2028 (%)
    • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • 10.16 Brazil - Market size and forecast 2023-2028
    • Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Chart on Brazil - Year-over-year growth 2023-2028 (%)
    • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • 10.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

11 Drivers, Challenges, and Opportunity/Restraints

  • 11.1 Market drivers
  • 11.2 Market challenges
  • 11.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 11.4 Market opportunities/restraints

12 Competitive Landscape

  • 12.1 Overview
  • 12.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 12.3 Landscape disruption
    • Overview on factors of disruption
  • 12.4 Industry risks
    • Impact of key risks on business

13 Competitive Analysis

  • 13.1 Companies profiled
    • Companies covered
  • 13.2 Company ranking index
    • Company ranking index
  • 13.3 Market positioning of companies
    • Matrix on companies position and classification
  • 13.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 13.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 13.6 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
    • SWOT
  • 13.7 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 13.8 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 13.9 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 13.10 ICON plc
    • ICON plc - Overview
    • ICON plc - Product / Service
    • ICON plc - Key offerings
    • SWOT
  • 13.11 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 13.12 Mithra Pharmaceuticals SA
    • Mithra Pharmaceuticals SA - Overview
    • Mithra Pharmaceuticals SA - Product / Service
    • Mithra Pharmaceuticals SA - Key offerings
    • SWOT
  • 13.13 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT

14 Appendix

  • 14.1 Scope of the report
  • 14.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 14.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 14.4 Research methodology
    • Research methodology
  • 14.5 Data procurement
    • Information sources
  • 14.6 Data validation
    • Data validation
  • 14.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 14.8 Data synthesis
    • Data synthesis
  • 14.9 360 degree market analysis
    • 360 degree market analysis
  • 14.10 List of abbreviations
    • List of abbreviations